Reduced-dose of bivalirudin (without the post-procedure infusion) in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention
In patients with UA and NSTEMI undergoing elective PCI, 80% of the recommended dose of bivalirudin without post-procedure infusion can be used for anticoagulation without increasing the risk of thrombosis and bleeding.
Authors
- Yang Lin (ORCID: https://orcid.org/0000-0001-8987-5505)
- Tienan Zhou
- Quanyu Zhang
- Zhiqiang Zhang (ORCID: https://orcid.org/0000-0001-7857-175X)
- Xiaozeng Wang (ORCID: https://orcid.org/0000-0003-1979-0287)
- Qian Wang (ORCID: https://orcid.org/0000-0002-2536-7533)
- Dongyuan Sun
- Yan Liu (ORCID: https://orcid.org/0000-0002-9147-3959)
Institutions
- General Hospital of Shenyang Military Region (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1186/s12872-024-04399-5
- Citations
- 1
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.40